Unique ID issued by UMIN | UMIN000008502 |
---|---|
Receipt number | R000009993 |
Scientific Title | Stereotactic body radiation therapy for hepatocellular carcinoma. |
Date of disclosure of the study information | 2012/07/23 |
Last modified on | 2017/10/02 10:00:33 |
Stereotactic body radiation therapy for hepatocellular carcinoma.
Stereotactic body radiation therapy for hepatocellular carcinoma.
Stereotactic body radiation therapy for hepatocellular carcinoma.
Stereotactic body radiation therapy for hepatocellular carcinoma.
Japan |
Hepatocellular carcinoma.
Hepato-biliary-pancreatic medicine | Radiology |
Malignancy
NO
We perform stereotactic body radiotherapy as additional treatment after the TACE for a local hepatocellular carcinoma (greatest dimension 5cm or less). Further we examine the effectiveness and safety and follow up them after this treatment.
Safety,Efficacy
Confirmatory
Pragmatic
Not applicable
Local tumor control rate, safety
overall survival rate, disease free survival rate
Observational
20 | years-old | <= |
90 | years-old | >= |
Male and Female
(1) hypervascular HCC nodules, each up to 50 mm in diameter; (2) not suitable for the hepatic resection or ablative therapy; (3) Child-Turcotte-Pugh (CTP) score<7.
neighboring the Intestinal tract
200
1st name | |
Middle name | |
Last name | Kazuaki Chayama |
Hiroshima university
Department of Medicine and Molecular Science
1-2-3 Kasumi, Minamiku, Hiroshima
082-257-5555
chayama@hiroshima-u.ac.jp
1st name | |
Middle name | |
Last name | Hiroshi Aikata |
Hiroshima university
Department of Medicine and Molecular Science
1-2-3 Kasumi, Minamiku, Hiroshima
082-257-5555
aikata@hiroshima-u.ac.jp
Hiroshima university hospital
Hiroshima university hospital
Self funding
NO
広島大学病院(広島)
2012 | Year | 07 | Month | 23 | Day |
Unpublished
Terminated
2012 | Year | 03 | Month | 16 | Day |
2012 | Year | 04 | Month | 01 | Day |
2016 | Year | 03 | Month | 31 | Day |
2016 | Year | 03 | Month | 31 | Day |
2017 | Year | 03 | Month | 31 | Day |
2017 | Year | 03 | Month | 31 | Day |
We perform stereotactic body radiotherapy as additional treatment after the TACE for a local hepatocellular carcinoma (greatest dimension 5cm or less). Further we examine the effectiveness and safety and follow up them after this treatment.
2012 | Year | 07 | Month | 23 | Day |
2017 | Year | 10 | Month | 02 | Day |
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000009993
Research Plan | |
---|---|
Registered date | File name |
Research case data specifications | |
---|---|
Registered date | File name |
Research case data | |
---|---|
Registered date | File name |